Investor Presentaiton
YTD 2023 Financial Review
//Andlauer
HEALTHCARE
• The year-over-year decline in net income and EBITDA is primarily attributable to reduced contributions from Boyle
Transportation and Skelton USA, lower outbound volume for Accuristix and lower air freight forwarding revenue in
Q2 2023, and the decline in revenue related to COVID-19 vaccines and ancillary products.
Six months ended
GROUP
(In 000s, except percentages and per share amounts)
Six months ended
June 30, 2023
June 30, 2022
Variance
Revenue
Logistics and Distribution
Packaging
$ 79,961
$ 75,090
6.5%
9,746
11,922
(18.3)%
Healthcare Logistics Segment
89,707
87,012
3.1%
Ground Transportation
211,711
203,826
3.9%
Air Freight Forwarding
15,220
19,130
(20.4)%
Dedicated and Last Mile Delivery
33,470
32,562
2.8%
Less: Intersegment Eliminations
(27,977)
(24,777)
12.9%
Specialized Transportation Segment
232,424
230,741
0.7%
Total Revenue
322,131
317,753
1.4%
Operating expenses
(275,846)
(263,434)
4.7%
Operating income
46,285
54,319
(14.8)%
Net Income
32,244
37,456
(13.9)%
Foreign currency translation adjustment
(5,239)
Total comprehensive income
$ 27,005
EPS (diluted)
$
0.76
$
EBITDA
EBITDA Margin
$ 80,009
24.8%
$ 85,713
27.0%
N/A
(34.2)%
$ (0.12)
(6.7)%
(220 bps)
3,608
$ 41,064
0.88
18View entire presentation